What are the Carpenter criteria for diagnosing diabetes in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Carpenter Criteria for Diagnosis of Diabetes in Pregnancy

The Carpenter-Coustan criteria diagnose gestational diabetes mellitus (GDM) when at least two of the following four plasma glucose values are met or exceeded during a 100-g oral glucose tolerance test (OGTT): fasting 95 mg/dL (5.3 mmol/L), 1-hour 180 mg/dL (10.0 mmol/L), 2-hour 155 mg/dL (8.6 mmol/L), and 3-hour 140 mg/dL (7.8 mmol/L). 1, 2

Two-Step Approach Using Carpenter-Coustan Criteria

Step 1: Initial Screening

  • Perform a 50-g glucose load test (GLT) at 24-28 weeks of gestation in women not previously diagnosed with diabetes 1
  • This test is performed without fasting (non-fasting) 1
  • Measure plasma glucose 1 hour after the glucose load 1, 2
  • If the 1-hour plasma glucose is ≥130,135, or 140 mg/dL (7.2,7.5, or 7.8 mmol/L), proceed to the diagnostic 100-g OGTT 1
  • Different threshold cutoffs have different test characteristics:
    • 140 mg/dL threshold: 85% sensitivity, 86% specificity 1
    • 130 mg/dL threshold: 99% sensitivity, 77% specificity 1

Step 2: Diagnostic Test

  • Perform a 100-g OGTT when the patient is fasting (after an overnight fast of at least 8 hours) 1, 2
  • Measure plasma glucose at fasting and at 1,2, and 3 hours after glucose load 1
  • Diagnosis of GDM is made when at least two of the four plasma glucose levels meet or exceed the Carpenter-Coustan criteria 1, 2:
    • Fasting: 95 mg/dL (5.3 mmol/L)
    • 1-hour: 180 mg/dL (10.0 mmol/L)
    • 2-hour: 155 mg/dL (8.6 mmol/L)
    • 3-hour: 140 mg/dL (7.8 mmol/L)
  • The American College of Obstetricians and Gynecologists (ACOG) notes that one elevated value can be used for diagnosis in some cases 1

Clinical Significance and Outcomes

  • GDM diagnosed by Carpenter-Coustan criteria is associated with increased risk of adverse maternal and fetal outcomes 2, 3
  • Treatment of GDM diagnosed using Carpenter-Coustan criteria has been shown to reduce:
    • Preeclampsia 1
    • Shoulder dystocia 1
    • Macrosomia 1
  • Women diagnosed with GDM have significantly increased risk for developing type 2 diabetes later in life 2
  • Infants of mothers with GDM diagnosed by Carpenter-Coustan criteria have cord serum insulin levels approximately 40% higher than those of negative screenees 3

Comparison with Other Diagnostic Criteria

  • The Carpenter-Coustan criteria are more sensitive than the older National Diabetes Data Group (NDDG) criteria 2, 4
  • The Carpenter-Coustan criteria identify approximately 50% more cases of GDM compared to NDDG criteria 3
  • The one-step IADPSG approach (75-g OGTT) is more sensitive than Carpenter-Coustan criteria but identifies more women as having GDM (15-20% vs. 5-6%) 1, 2
  • The American Diabetes Association (ADA) recommends the IADPSG criteria, while ACOG continues to support the two-step approach with Carpenter-Coustan criteria 1, 2

Clinical Considerations and Pitfalls

  • There is no established gold standard for GDM diagnosis, which limits the ability to compare different diagnostic criteria 1
  • The choice between one-step IADPSG approach and two-step Carpenter-Coustan approach involves considerations of healthcare resources and potential "medicalization" of pregnancies 2
  • In low-risk populations, selective screening based on risk factors may be considered, as less than 1% of women without risk factors develop GDM 5
  • When using the 50-g GLT screening test, lowering the threshold from 140 mg/dL to 136 mg/dL increases sensitivity but also increases false positives and healthcare costs 4
  • The 100-g OGTT remains the "gold standard" for diagnosing GDM when using the Carpenter-Coustan criteria 6

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.